Introducing NACI newest recommendations regarding the use of Hepatitis B vaccine

Canada
NITAGs
29 March 2017

NACI have released the update on the recommended use of Hepatitis B vaccine. It includes 4 main recommendations:

  1. NACI does not recommend routine booster doses of HB vaccine for immunocompetent individuals following the completion of a recommended HB immunization schedule given in infancy.
  2. NACI recommends that adults with diabetes need not be considered as a separate high risk group for immunization with HB vaccine.
  3. For immunocompromised individuals, initial annual monitoring of HB antibody levels following HB immunization may be considered
  4. Immunization with HB-containing vaccine should be provided according to determined provincial and territorial (P/T) schedules.

ca.png
Documents to download

Related News & Events

  • 25 -26
    October
    United States of America
    NITAGs

    MEETING OF THE ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP)

    1600 Clifton Road, NE, Tom Harkin Global Communications Center, Kent "Oz" Nelson Auditorium
  • Costa Rica
    NITAGs

    Costa Rica introduces two new vaccines into the national immunization program

    16.10.2017

    October 2017 marks the introduction of the rotavirus and human papillomavirus (HPV) vaccines in Costa Rica’s immunization program. This decision results from the recommendations of the country National Immunization Technical Advisory Group (NITAG). Since 2001, Costa Rica’s NITAG, which is called Comisión Nacional de Vacunación y Epidemiología (National Commission on Vaccination and Epidemiology), is in charge of establishing and periodically updating the national immunization schedule as well as formulating overall policies and strategies for immunization. In order to issue the recommendations, the NITAG conducted cost-effectiveness studies that were then approved by its members.

    Read more
  • Canada
    NITAGs

    NACI mandate expands to support local decision-making on vaccine programs

    28.07.2017

    In June 2016 the Public Health Agency of Canada (PHAC) announced that the mandate of Canada’s NITAG, the National Advisory Committee on Immunization (NACI) will be expanded. In addition to the assessment of vaccine characteristics (safety, efficacy, effectiveness, and immunogenicity), NACI will also be assessing additional programmatic elements including economic evaluations, feasibility of implementation, acceptability, ethics and equity. 

    Read more